MediMabBio is pleased to announce our poster presentation at the upcoming EACR2024 conference, where we will update our latest advancements in cancer therapy research.

Event: EACR2024 (10-13 June 2024, Rotterdam)
Presentation Title: Development of a Novel Anti-TIGIT IL-15 Fusion Antibody for Enhanced Anti-Tumour Therapy

Our research team will share valuable insights into the development of a novel anti-TIGIT IL-15 fusion antibody, which holds significant promise for enhancing anti-tumor therapies. This innovative approach highlights our commitment to pioneering advancements in cancer treatment.

We look forward to engaging with fellow researchers, industry experts, and partners at EACR2024, fostering collaborations and discussions that will drive the future of cancer research.

Stay tuned for more updates and detailed findings from the conference.